ATE392203T1 - Verfahren zur verkapselung eines wirkstoffs - Google Patents

Verfahren zur verkapselung eines wirkstoffs

Info

Publication number
ATE392203T1
ATE392203T1 AT02735680T AT02735680T ATE392203T1 AT E392203 T1 ATE392203 T1 AT E392203T1 AT 02735680 T AT02735680 T AT 02735680T AT 02735680 T AT02735680 T AT 02735680T AT E392203 T1 ATE392203 T1 AT E392203T1
Authority
AT
Austria
Prior art keywords
active substance
inter
coating
product
encapsulating
Prior art date
Application number
AT02735680T
Other languages
English (en)
Inventor
Francis Moolman
Heidi Rolfes
Der Merwe Thilo Van
Original Assignee
Csir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25589180&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE392203(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Csir filed Critical Csir
Application granted granted Critical
Publication of ATE392203T1 publication Critical patent/ATE392203T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
  • Paints Or Removers (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT02735680T 2001-05-30 2002-05-28 Verfahren zur verkapselung eines wirkstoffs ATE392203T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA200104451 2001-05-30

Publications (1)

Publication Number Publication Date
ATE392203T1 true ATE392203T1 (de) 2008-05-15

Family

ID=25589180

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02735680T ATE392203T1 (de) 2001-05-30 2002-05-28 Verfahren zur verkapselung eines wirkstoffs

Country Status (21)

Country Link
US (1) US7641917B2 (de)
EP (1) EP1401404B1 (de)
JP (1) JP4313196B2 (de)
CN (1) CN1255099C (de)
AT (1) ATE392203T1 (de)
AU (1) AU2002310567B2 (de)
BR (1) BR0210000A (de)
CA (1) CA2455208C (de)
CH (1) CH695418A5 (de)
CY (1) CY1108199T1 (de)
DE (2) DE10296849T5 (de)
DK (1) DK1401404T3 (de)
ES (1) ES2305250T3 (de)
FR (1) FR2825292B1 (de)
GB (1) GB2392619B (de)
HK (1) HK1066488A1 (de)
IT (1) ITMI20021169A1 (de)
NL (1) NL1020706C2 (de)
PT (1) PT1401404E (de)
WO (1) WO2003013478A2 (de)
ZA (1) ZA200309983B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE392203T1 (de) 2001-05-30 2008-05-15 Csir Verfahren zur verkapselung eines wirkstoffs
US7903319B2 (en) * 2006-07-11 2011-03-08 E Ink Corporation Electrophoretic medium and display with improved image stability
US20080082764A1 (en) * 2006-10-03 2008-04-03 Yi Feng Jang Memory accessing system and method
GB0812742D0 (en) * 2008-07-11 2008-08-20 Critical Pharmaceuticals Ltd Process
GB201317756D0 (en) 2013-10-08 2013-11-20 Critical Pharmaceuticals Ltd New process
DE102018210030A1 (de) * 2018-06-20 2019-12-24 Thyssenkrupp Ag Verwendung und Recyclieren von überkritischen CO2 als Lösungsmittel für PLA und weitere biologisch abbaubaren Polymere in das Beschichtungsverfahren für Düngemittel
IT201800007993A1 (it) * 2018-08-09 2020-02-09 Greenbone Ortho Srl Impianto finalizzato alla trasformazione chimica di materiali nello stato 3d
CN112812355B (zh) * 2020-12-31 2022-09-23 厦门天生爱科技有限公司 一种具有缓释挥发性中草药有效成分的功能高分子发泡材料、制备方法和用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8500121D0 (en) 1985-01-03 1985-02-13 Connaught Lab Microencapsulation of living cells
ES2043640T3 (es) * 1987-12-21 1994-01-01 Union Carbide Corp Fluidos supercriticos como diluyentes en la aplicacion por rociada liquida de revestimientos.
EP0706821A1 (de) * 1994-10-06 1996-04-17 Centre De Microencapsulation Verfahren zum Beschichten von Partikeln
US5939485A (en) * 1995-06-19 1999-08-17 Medlogic Global Corporation Responsive polymer networks and methods of their use
DE69617245T2 (de) * 1995-08-17 2002-07-25 Csir Pretoria Produkte mit gesteuerter freisetzung
FR2753639B1 (fr) 1996-09-25 1998-12-11 Procede de preparation de microcapsules de matieres actives enrobees par un polymere et nouvelles microcapsules notamment obtenues selon le procede
US5766637A (en) * 1996-10-08 1998-06-16 University Of Delaware Microencapsulation process using supercritical fluids
US6221300B1 (en) * 1997-02-17 2001-04-24 Doppel Co., Ltd. Method for manufacturing artificial stone
GB9800936D0 (en) 1997-05-10 1998-03-11 Univ Nottingham Biofunctional polymers
WO1999019085A1 (en) 1997-10-15 1999-04-22 University Of South Florida Supercritical fluid aided coating of particulate material
IT1296464B1 (it) 1997-11-19 1999-06-25 Vectorpharma Int Composizioni farmaceutiche in forma di polveri di polimeri reticolati caricati con farmaci e relativo processo di preparazione mediante
GB9814619D0 (en) 1998-07-06 1998-09-02 Cole Polytechnique Fudurale De Materials and methods relating to encapsulation
US6340722B1 (en) 1998-09-04 2002-01-22 The University Of Akron Polymerization, compatibilized blending, and particle size control of powder coatings in a supercritical fluid
US6350786B1 (en) * 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
GB9920558D0 (en) 1999-08-31 1999-11-03 Bradford Particle Design Ltd Methods for particle formation and their products
US6372259B1 (en) * 1999-11-10 2002-04-16 University Of Iowa Research Foundation Palatable, sustained release drug granules
US6521258B1 (en) * 2000-09-08 2003-02-18 Ferro Corporation Polymer matrices prepared by supercritical fluid processing techniques
WO2002020624A1 (en) 2000-09-08 2002-03-14 Ferro Corporation Controlled-release pharmaceuticals prepared by supercritical fluid processing techniques
ATE392203T1 (de) 2001-05-30 2008-05-15 Csir Verfahren zur verkapselung eines wirkstoffs

Also Published As

Publication number Publication date
FR2825292A1 (fr) 2002-12-06
WO2003013478A3 (en) 2003-05-30
DE60226140T2 (de) 2009-05-07
CY1108199T1 (el) 2014-02-12
ZA200309983B (en) 2005-01-26
JP2005502642A (ja) 2005-01-27
NL1020706A1 (nl) 2002-12-03
WO2003013478A8 (en) 2003-04-03
DK1401404T3 (da) 2008-08-11
CN1512877A (zh) 2004-07-14
AU2002310567B2 (en) 2005-10-20
CN1255099C (zh) 2006-05-10
US20050112205A1 (en) 2005-05-26
GB0327381D0 (en) 2003-12-31
CA2455208A1 (en) 2003-02-20
EP1401404B1 (de) 2008-04-16
ITMI20021169A1 (it) 2003-12-01
NL1020706C2 (nl) 2003-04-28
DE10296849T5 (de) 2004-04-29
HK1066488A1 (en) 2005-03-24
GB2392619A (en) 2004-03-10
WO2003013478A2 (en) 2003-02-20
CA2455208C (en) 2009-02-03
JP4313196B2 (ja) 2009-08-12
CH695418A5 (de) 2006-05-15
EP1401404A2 (de) 2004-03-31
ITMI20021169A0 (it) 2002-05-30
US7641917B2 (en) 2010-01-05
FR2825292B1 (fr) 2006-06-09
BR0210000A (pt) 2004-05-04
DE60226140D1 (de) 2008-05-29
PT1401404E (pt) 2008-07-23
ES2305250T3 (es) 2008-11-01
GB2392619B (en) 2004-10-20

Similar Documents

Publication Publication Date Title
ATE297196T1 (de) Verfahren zur herstellung von nanometer partikeln durch fliessbett- sprühtrocknung
DE60140625D1 (de) Verfahren zur herstellung von mikropartikeln
DE69905460D1 (de) Verfahren und vorrichtung zur herstellung von partikeln
DE60211004D1 (de) Pulververarbeitung mit unter druck stehenden gasförmigen fluids
CA2327522A1 (en) Incorporation of active substances in carrier matrixes
DE69823806D1 (de) Verfahren und vorrichtung zur herstellung von teilchen
WO2005098083A3 (en) Miniature microwave plasma torch application and method of use thereof
DE50005599D1 (de) Verfahren zur herstellung von morphologisch einheitlichen mikro- und nanopartikeln mittels eines mikromischers
MXPA05007154A (es) Atomizador prepeliculizacion.
ATE314055T1 (de) Zubereitungen enthaltend mikropartikel von wasserunlöslichen stoffen und verfahren zu deren herstellung
WO2005023923A3 (en) Methods of processing nanocrystals, and compositions, devices and systems including same
MXPA04000201A (es) Metodo y aparato para preparar particulas.
ATE392203T1 (de) Verfahren zur verkapselung eines wirkstoffs
AU2001291647A1 (en) Coated particles containing an active substance
DE602004014124D1 (de) Verfahren zur dispersion von wasserlöslichen oder hydrophilen substanzen in einem unter überkritischem druck stehenden fluid
SI1572315T1 (sl) Naprava in postopek za izolacijo proizvedenih delcev kot suspenzija v ne-superkritičnem fluidu
ATE334159T1 (de) Verfahren zur herstellung von gut in wasser redispergierbaren und mit wasser benetzbaren polymerisatpulvern
EE05101B1 (et) Seade ja meetod vedelike t””tlemiseks ultraheliga
ATE314157T1 (de) Verfahren zum aufbringen eines hydrophoben films und gegenstand damit beschichtet
FR2821778B1 (fr) Procede d'assemblage automatisee de structures volumineuses notamment aeronautiques, dispositifs et produit logiciel permettant de le mettre en oeuvre
SE0202360D0 (sv) System and method for improving the movement and discharge of material from vessels
ATE368451T1 (de) Verfahren zum überziehen von feststoffteilchen
WO2006016981A3 (en) Production of porous materials by supercritical fluid processing
EP1550501A3 (de) Verfahren und Vorrichtung zur Herstellung eines fliessfähigen pulverförmigen Materials
WO2002100378A3 (en) Process for the preparation of a particulate material

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1401404

Country of ref document: EP